Association of PSA level with thiols content in patients with prostate carcinoma
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F12%3A00198376" target="_blank" >RIV/62156489:43210/12:00198376 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Association of PSA level with thiols content in patients with prostate carcinoma
Original language description
To detect prostate carcinoma, prostatic specific antigen (PSA) is mostly used. However diagnostics of this tumour disease can become more precise using other types of molecules [1]. In this study we aimed at determination of reduced (GSH) and oxidized (GSSG) glutathione and its ratio and level of metallothionein in blood of patients with prostate carcinoma. The obtained results were correlated with PSA levels determined in blood of patients. Analyses were performed in 35 patients with prostate cancer atthe age of 54 to 79 years with an average of 66 years and in 8 healthy subjects who formed the control group. PSA levels in patients ranged from 1.4 to 6.4 ng*ml-1 with an average of 2.4 ng*ml-1, GSH/GSSG from 0.6 to 6.7 with an average of 4.3 and metallothionein content ranged from 0.97 to 2.42 uM with an average of 1.91 uM. In the control group PSA values ranged from 0.06 to 0.14 ng*ml-1 with an average of 0.11 ng*ml-1, GSH/GSSG from 7.8 to 13.8 with an average of 9.4 and metallothion
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CE - Biochemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GAP301%2F10%2F0356" target="_blank" >GAP301/10/0356: Study of contribution of different DNA-damaging mechanisms to toxicity of cytostatics to human chemosensitive and chemoresistant neuroblastomas</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Molecular Medicine
ISSN
1107-3756
e-ISSN
—
Volume of the periodical
30
Issue of the periodical within the volume
1
Country of publishing house
GR - GREECE
Number of pages
1
Pages from-to
47
UT code for WoS article
—
EID of the result in the Scopus database
—